Medical Device Innovation Consortium

The Medical Device Innovation Consortium (MDIC) is the first-ever public-private partnership created with the sole objective of advancing medical device regulatory science for patient benefit. Formed in late 2012, MDIC brings together representatives of the FDA, NIH, CMS, industry, and non-profits and patient organizations to improve the processes for development, assessment and review of new medical technologies. Our work is unique and complementary to trade associations such as AdvaMed and MDMA. Members of MDIC share a vision of providing U.S. patients with timely access to high-quality, safe and effective medical devices.

MDIC is a non-profit 501(c)3 organization, governed by a Board of Directors, that represents public and private sectors, and patient advocacy groups. Our board includes the director of CDRH, the director of Coverage and Analysis at CMS, C-level executives representing patient organizations, non-profits and industry. A listing of current board members is included at the end of this document. MDIC works on science, not policy. Participation in MDIC is open to representatives of organizations that are substantially involved in medical and/or medical device research, development, treatment, or education; organizations that promote public health; and organizations with expertise in regulatory science. MDIC has 59 member organizations; approximately one-third are government or not for profit, one-quarter are larger companies with revenue greater than $1B, one-third are companies with revenue less than $1B and the balance are pre-revenue companies.